A detailed history of Centric Wealth Management transactions in Braskem Sa stock. As of the latest transaction made, Centric Wealth Management holds 74,141 shares of BAK stock, worth $436,690. This represents 0.15% of its overall portfolio holdings.

Number of Shares
74,141
Previous 20,953 253.84%
Holding current value
$436,690
Previous $220,000 117.27%
% of portfolio
0.15%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.45 - $10.37 $343,062 - $551,559
53,188 Added 253.84%
74,141 $478,000
Q1 2024

May 01, 2024

SELL
$6.85 - $10.9 $68,513 - $109,021
-10,002 Reduced 32.31%
20,953 $220,000
Q4 2023

Feb 06, 2024

SELL
$6.39 - $9.07 $830,731 - $1.18 Million
-130,005 Reduced 80.77%
30,955 $273,000
Q3 2023

Nov 03, 2023

BUY
$7.99 - $11.53 $1.29 Million - $1.86 Million
160,960 New
160,960 $1.32 Million

Others Institutions Holding BAK

About BRASKEM SA


  • Ticker BAK
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Chemicals
  • Shares Outstandng 398,152,000
  • Market Cap $2.35B
  • Description
  • Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; f...
More about BAK
Track This Portfolio

Track Centric Wealth Management Portfolio

Follow Centric Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.